CD19 car circRNA-LNP
CAT:
804-HY-153234
Size:
Inquire
Price:
Ask
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No
CD19 car circRNA-LNP
- UNSPSC Description: CD19 car circRNA-LNP is a lipid nanoparticle (LNP) containing CD19 car circRNA, suitable for detection of RNA delivery, translation efficiency, cell viability, etc. CD19 car circRNA can be used in chimeric antigen receptor T cell immunotherapy (CAR-CD19). The CD19 car is a chimeric antigen receptor. Among them, CD19 is a CD molecule expressed by B cells (i.e. leukocyte differentiation antigen), an important membrane antigen involved in B cell proliferation, differentiation, activation and antibody production, and can also promote BCR signal transduction[1][2].
- Target Antigen: CD19; Liposome
- Type: Biochemical Assay Reagents
- Related Pathways: Immunology/Inflammation;Metabolic Enzyme/Protease
- Applications: COVID-19-immunoregulation
- Field of Research: Cancer; Inflammation/Immunology
- Assay Protocol: https://www.medchemexpress.com/cd19-car-circrna-lnp.html
- Solubility: 10 mM in DMSO
- Smiles: [CD19 car circRNA-LNP]
- References & Citations: [1]Xu Y, et al. Closely related T-memory stem cells correlate with in vivo expansion of CAR.CD19-T cells and are preserved by IL-7 and IL-15. Blood. 2014 Jun 12;123(24):3750-9. |[2]Li X, et al. CD19, from bench to bedside. Immunol Lett. 2017 Mar;183:86-95.
- Shipping Conditions: Room temperature
- Clinical Information: No Development Reported